UK Regulator Stalls Demant’s Oticon Medical Divestment
A potential ruling by the UK Competition and Markets Authority has stalled Demant’s divestment of Oticon Medical to Cochlear Limited.
Tag: Cochlear Limited
All
Latest
Frequency Therapeutics Appoints Kevin Franck as SVP
Dr Franck will lead pre-commercial strategy and launch planning for Frequency’s clinical pipeline, including its lead program aimed at developing a restorative treatment for sensorineural hearing loss (SNHL), the most common form of hearing loss.
All
Latest
Cochlear Announces FDA Approval for Cochlear Implantation at 9 Months
The research and support in practice by trained hearing health professionals provided the foundation to approve the indication be lowered to 9 months, along with the considerable developments in technology and evolving speech coding strategies in modern day cochlear implant devices.
Cochlear Osia 2 System Receives FDA Clearance
Cochlear Limited (ASX: COH), an implantable hearing solutions company, announced the US Food and...
Read More
‘Life After Deaf’ Details Reporter’s Experience with Hearing Loss
A Pulitzer-Prize nominated reporter has penned Life After Deaf, a new book detailing his...
Read More
Cochlear Celebration to Take Place February 14-17 in Nashville
More than 1,000 Cochlear™ Nucleus® Implant and Baha® System recipients and their families from the United States and Canada will come together at the four-day convention to celebrate the joys, challenges, and personal triumphs of overcoming hearing loss, while improving their hearing performance.
Read More
Cochlear and GN Expand Smart Hearing Alliance Collaboration
The deepening of this relationship includes joint research and development, shared technology, and strengthened global Smart Hearing Alliance commercial collaboration between Cochlear and GN Hearing, the hearing aid division of the GN Group.
Read More
Cochlear Ltd to Appeal $268 Million Patent Infringement Judgement
A US District Court has awarded $268.1 million in damages against Cochlear Ltd as part of a patent infringement lawsuit filed by the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics LLC.
Read More
Cochlear Limited Announces Next Phase in Development of Totally Implantable Cochlear Implant
For this next phase of research and development, a further clinical feasibility study has been initiated to evaluate the totally implantable cochlear implant technology.
Read More
University of Sydney and Cochlear Limited Study Speech Comprehension in Cochlear Implant Recipients
In the study, recently published in “Ear and Hearing,” experts have found a correlation between a computer model and the speech intelligibility in implant recipients. This might mean that by improving the performance of the model, the performance of individuals with cochlear implants may benefit in ways that have never before been explored.
Read More
Sensorion Presents SENS-401 Data at Ci2018 Conference
Data from the presented studies showed that SENS-401 protected inner ear function and enhanced sensory hair cell survival in preclinical models of acoustic trauma and, separately, cisplatin infusion.
Read More
Cochlear Announces Upcoming Release of Nucleus Smart App for Android
Cochlear implant recipients with the Nucleus® 7 Sound Processor can now control their hearing with the Nucleus Smart App from a compatible Android device, which is designed to allow them to monitor and adjust their settings, view personalized hearing information, and even locate a missing sound processor, all from the convenience of their smartphone.
Read More
Cochlear Pledges $10 Million to Johns Hopkins for Research on Impact of Hearing Loss
The Cochlear Center for Hearing and Public Health at Johns Hopkins will be a first of its kind at any academic institution, focusing on hearing loss as a global public health priority, and it will be led by one of the preeminent researchers in this area, Frank Lin, MD, PhD. The center will be dedicated to understanding and addressing the impact of hearing loss on public health.
Read More
Cochlear Limited Announces Winners of 2018 Graeme Clark and Anders Tjellström Scholarships
The scholarships, named after two pioneers of the hearing implant industry, recognize Cochlear™ Nucleus® Implant and Baha® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership and humanity, and demonstrate high academic achievement.
Read More
Neuromod Appoints Dr Hubert Lim as Chief Scientific Officer
Lim’s work has a strong focus on the improvement of invasive and non-invasive neurostimulation approaches for treating unmet medical needs in hearing and other therapeutic areas.
Read More
Cochlear Limited Announces Release of Baha SoundArc
The Baha SoundArc was designed to provide children with conductive hearing loss, mixed hearing loss, or single-sided sensorineural deafness (SSD) with the hearing performance and amplification they need to facilitate language development on par with their hearing peers.
Read More
Cochlear Receives FDA Approval for Remote Feature on Nucleus Cochlear Implant System
Leveraging telehealth within the cochlear implant industry provides clinics with more options to care for their patients no matter where their office is located, and it allows Nucleus Cochlear Implant recipients to receive care from the comfort of their own home.
Read More
Cochlear Limited Partnering with Apple on iPhone-Compatible Cochlear Implant, CNN Reports
The Nucleus Cochlear implant will allow users direct streaming of music, calls, and movies, similar to the features that modern hearing aids are equipped with.
Read More